Dallapiccola B, Novelli G, Micara G, Ferranti G, Pachi A, Magnani M
Prenat Diagn. 1983 Oct;3(4):337-41. doi: 10.1002/pd.1970030410.
Glutamic-oxaloacetic transaminase (GOT1) gene dosage studies were performed on uncultured amniotic cells from a fetus at risk for duplication/deficiency of 10q24 leads to qter, due to maternal translocation t(9;10)(p24;q24). Previous investigations in the same pedigree had shown triplex dosage effect of GOT1 on red blood cells of a 10q24 leads to qter trisomic fetus monitored by midtrimester amniocentesis. In the present pregnancy, the GOT1 activity of amniotic cells exhibited a triplex gene dosage, suggesting duplication of region 10q24 leads to qter in the fetus. The biochemical prediction was confirmed two weeks later by cytogenetic analysis.
对一名因母亲易位t(9;10)(p24;q24)而有10q24至qter重复/缺失风险的胎儿的未培养羊水细胞进行了谷氨酸草酰乙酸转氨酶(GOT1)基因剂量研究。之前在同一谱系中的调查显示,通过孕中期羊膜穿刺术监测的一名10q24至qter三体胎儿的红细胞中,GOT1存在三联体剂量效应。在本次妊娠中,羊水细胞的GOT1活性表现出三联体基因剂量,提示胎儿中10q24至qter区域重复。两周后通过细胞遗传学分析证实了这一生化预测。